Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of Century Therapeutics Inc (NASDAQ: IPSC) closed at $0.57 in the last session, down -0.54% from day before closing price of $0.57. In other words, the price has decreased by -$0.54 from its previous closing price. On the day, 0.81 million shares were traded.
Ratios:
We take a closer look at IPSC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.70 and its Current Ratio is at 11.70. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 08, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On August 28, 2023, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $28 to $5.
On December 27, 2022, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $19.Chardan Capital Markets initiated its Buy rating on December 27, 2022, with a $19 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 16 ’25 when Pfeiffenberger Brent sold 29,552 shares for $0.55 per share. The transaction valued at 16,135 led to the insider holds 1,682,258 shares of the business.
Pfeiffenberger Brent bought 29,552 shares of IPSC for $16,138 on May 16 ’25. On May 05 ’25, another insider, Farid Adrienne, who serves as the Chief Operations Officer of the company, sold 1,024 shares for $0.55 each. As a result, the insider received 563 and left with 250,693 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.43 while its Price-to-Book (P/B) ratio in mrq is 0.20.
Stock Price History:
Over the past 52 weeks, IPSC has reached a high of $3.46, while it has fallen to a 52-week low of $0.34. The 50-Day Moving Average of the stock is 9.19%, while the 200-Day Moving Average is calculated to be -45.09%.
Shares Statistics:
A total of 86.15M shares are outstanding, with a floating share count of 40.59M. Insiders hold about 52.89% of the company’s shares, while institutions hold 28.86% stake in the company.
